Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 41.69% is in line with its 5-year average of 45.38%, near the high end of its 5-year range (-17.09%–62.35%).
As of the fiscal period ended Tuesday, March 31, 2026. 9.16% below its 12-month average of 45.89%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
41.69%
OPERATING MARGIN AVG TTM
45.89%
OPERATING MARGIN AVG 3Y
48.14%
OPERATING MARGIN AVG 5Y
48.51%
OPERATING MARGIN AVG 10Y
48.69%
OPERATING MARGIN AVG 15Y
47.56%
OPERATING MARGIN AVG 20Y
37.40%
CURRENT VS TTM AVG
-9.16%
CURRENT VS 3Y AVG
-13.40%
CURRENT VS 5Y AVG
-14.05%
CURRENT VS 10Y AVG
-14.38%
CURRENT VS 15Y AVG
-12.35%
CURRENT VS 20Y AVG
+11.47%
SECTOR MEDIAN · HEALTHCARE
15.01%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+177.74%
vs the sector median at left
United Therapeutics Corporation
Market Cap
$21.97B
Operating Margin
41.69%
TTM Avg
45.89%
3Y Avg
48.14%
5Y Avg
48.51%
Market Cap
$22.87B
Operating Margin
-158.13%
TTM Avg
-140.72%
3Y Avg
-73.36%
5Y Avg
-52.24%
Market Cap
$20.32B
Operating Margin
-18.62%
TTM Avg
-9.28%
3Y Avg
-0.91%
5Y Avg
-0.93%
Market Cap
$24.45B
Operating Margin
20.64%
TTM Avg
20.32%
3Y Avg
22.80%
5Y Avg
22.92%
Market Cap
$24.56B
Operating Margin
31.57%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$24.56B
Operating Margin
28.22%
TTM Avg
28.07%
3Y Avg
28.30%
5Y Avg
28.33%
Market Cap
$18.59B
Operating Margin
15.61%
TTM Avg
16.64%
3Y Avg
15.15%
5Y Avg
12.43%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | $21.97B | 41.69% | 45.89% | 48.14% | 48.51% |
| Moderna, Inc. (MRNA)vs › | $22.87B | -158.13% | -140.72% | -73.36% | -52.24% |
| STERIS plc (STE)vs › | $22.68B | 18.56% | 17.21% | 17.04% | 16.18% |
| BioNTech SE (BNTX)vs › | $23.32B | -22.63% | -35.20% | 5.18% | 14.03% |
| Viatris Inc. (VTRS)vs › | $20.32B | -18.62% | -9.28% | -0.91% | -0.93% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.45B | 20.64% | 20.32% | 22.80% | 22.92% |
| Incyte Corporation (INCY)vs › | $24.56B | 31.57% | 14.26% | 15.92% | 12.23% |
| Waters Corporation (WAT)vs › | $24.56B | 28.22% | 28.07% | 28.30% | 28.33% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.59B | 15.61% | 16.64% | 15.15% | 12.43% |
| Labcorp Holdings Inc. (LH)vs › | $25.46B | 11.27% | 9.61% | 9.32% | 13.00% |
Gross Margin
86.6%
Operating Margin
41.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 41.69% |
| 2025-12-31 | 45.24% |
| 2025-09-30 | 48.69% |
| 2025-06-30 | 45.64% |
| 2025-03-31 | 48.19% |
| 2024-12-31 | 48.61% |
| 2024-09-30 | 45.81% |
| 2024-06-30 | 44.75% |
| 2024-03-31 | 52.57% |
| 2023-12-31 | 42.31% |
| 2023-09-30 | 53.66% |
| 2023-06-30 | 52.54% |
| 2023-03-31 | 56.11% |
| 2022-12-31 | 35.73% |
| 2022-09-30 | 60.91% |
| 2022-06-30 | 43.22% |
| 2022-03-31 | 62.35% |
| 2021-12-31 | 40.90% |
| 2021-09-30 | 51.43% |
| 2021-06-30 | 49.76% |
| 2021-03-31 | -17.09% |
| 2020-12-31 | 16.97% |
| 2020-09-30 | 58.17% |
| 2020-06-30 | 38.81% |
| 2020-03-31 | 46.79% |
| 2019-12-31 | 20.41% |
| 2019-09-30 | 45.68% |
| 2019-06-30 | 59.26% |
| 2019-03-31 | -180.89% |
| 2018-12-31 | 34.48% |
| 2018-09-30 | 36.25% |
| 2018-06-30 | 48.91% |
| 2018-03-31 | 78.85% |
| 2017-12-31 | 29.91% |
| 2017-09-30 | 72.68% |
| 2017-06-30 | 19.91% |
| 2017-03-31 | 71.15% |
| 2016-12-31 | 42.59% |
| 2016-09-30 | 58.45% |
| 2016-06-30 | 69.12% |
| 2016-03-31 | 98.56% |
| 2015-12-31 | 38.30% |
| 2015-09-30 | 100.22% |
| 2015-06-30 | 49.46% |
| 2015-03-31 | -4.53% |
| 2014-12-31 | 51.56% |
| 2014-09-30 | -9.77% |
| 2014-06-30 | 54.62% |
| 2014-03-31 | 74.68% |
| 2013-12-31 | -9.86% |
| 2013-09-30 | 34.63% |
| 2013-06-30 | 43.59% |
| 2013-03-31 | 38.36% |
| 2012-12-31 | 52.75% |
| 2012-09-30 | 33.29% |
| 2012-06-30 | 46.81% |
| 2012-03-31 | 52.27% |
| 2011-12-31 | 32.54% |
| 2011-09-30 | 51.04% |
| 2011-06-30 | 73.83% |
| 2011-03-31 | 22.27% |
| 2010-12-31 | 5.44% |
| 2010-09-30 | 36.19% |
| 2010-06-30 | 44.24% |
| 2010-03-31 | 25.02% |
| 2009-12-31 | -2.00% |
| 2009-09-30 | 12.07% |
| 2009-06-30 | -4.91% |
| 2009-03-31 | 25.80% |
| 2008-12-31 | -176.45% |
| 2008-09-30 | 24.07% |
| 2008-06-30 | 27.70% |
| 2008-03-31 | 23.78% |
| 2007-12-31 | -14.02% |
| 2007-09-30 | 23.98% |
| 2007-06-30 | 15.52% |
| 2007-03-31 | -18.68% |
| 2006-12-31 | 7.74% |
| 2006-09-30 | 28.30% |
| 2006-06-30 | 28.61% |
| 2006-03-31 | 7.49% |
| 2005-12-31 | 34.93% |
| 2005-09-30 | 44.03% |
| 2005-06-30 | 37.14% |
| 2005-03-31 | 29.47% |
| 2004-12-31 | 29.21% |
| 2004-09-30 | 28.50% |
| 2004-06-30 | 19.51% |
| 2004-03-31 | -17.34% |
| 2003-12-31 | -25.92% |
| 2003-09-30 | -11.59% |
| 2003-06-30 | -20.23% |
| 2003-03-31 | -31.96% |
| 2002-12-31 | -25.89% |
| 2002-09-30 | -127.48% |
| 2002-06-30 | -11.92% |
